Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Teddy Cambosa

Hims Stock Tumbles Down After Abrupt Exit of Novo Nordisk: Here's Everything That Went Wrong

Hims & Hers, a popular telehealth company, has recently seen its stocks plummet after a bombshell partnership exit from pharmaceutical giant Novo Nordisk.

The update, which comes as a shock for the current pharmaceutical scene, follows Novo Nordisk's allegations that Hims & Hers released counterfeit products and engaged in deceptive marketing practices.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.